| Financial Year |
March 31 2023 |
| Monetary Funds |
789,968,297.97 |
| Held-for-trading Financial Assets |
112,000,000.00 |
| Notes Receivable |
556,313,381.11 |
| Accounts Receivable |
2,179,088,367.26 |
| Advances to Suppliers |
80,533,408.32 |
| Other Receivables |
69,107,217.73 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
520,452,777.25 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
95,256,531.18 |
| Total Current Assets |
4,492,864,351.34 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
105,165,578.19 |
| Investment Properties |
-- |
| Fixed Assetes |
1,667,293,825.68 |
| Under-construction Projects |
194,790,183.14 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
455,142,446.21 |
| R&D expenses |
-- |
| Goodwill |
149,456,281.91 |
| Long-Term Deferred and Prepaid Expenses |
85,768,088.23 |
| Deferred Income Tax Assets |
90,137,977.74 |
| Other Non-Current Assets |
54,515,265.85 |
| Sub-Total of Non-Current Assets |
2,854,351,244.70 |
| Total Assets |
7,347,215,596.04 |
| Short-Term Loans |
601,150,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
471,306,340.06 |
| Accounts Payable |
246,782,582.86 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
24,895,086.97 |
| Taxes Payable |
56,635,440.59 |
| Interest Payable |
10,584,825.26 |
| Dividend Payable |
11,400,000.00 |
| Other payables |
86,901,222.22 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
16,705,636.22 |
| Other Current Liabilities |
10,116,051.69 |
| Sub-Total of Current Liabilities |
1,597,426,066.76 |
| Long-term Loans |
211,855,000.00 |
| Bonds Payable |
682,047,540.85 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
32,328,802.58 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,088,794,363.93 |
| Total Liabilities |
2,686,220,430.69 |
| Paid-In Capital(Or Share Stock) |
420,310,121.00 |
| Capital Surplus |
1,734,968,525.57 |
| Surplus Reserve |
178,130,059.21 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,796,921,315.62 |
| Minority Stockholder's Interest |
427,486,719.21 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,233,508,446.14 |
| Owner's Equity（Stockholder's Equity） |
4,660,995,165.35 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,347,215,596.04 |
